Could Aphria Inc. or Aurora Cannabis Inc. Dethrone Canopy Growth Corp.?

Aphria Inc. has been soaring since its graduation to the TSX last month. The company now has a $1.1 billion market cap and could pass Canopy Growth Corp. with its $1.74 billion market cap over the next few months. There’s no question Canopy stock has slowed down when compared to its peers like Aphria and Aurora Cannabis Inc

The post Could Aphria Inc. or Aurora Cannabis Inc. Dethrone Canopy Growth Corp.? appeared first on Marijuana Industry News.

Cannabis Industry Attracts More Mainstream Investors as Business Grows

Courtesy of Ted Chung Snoop Dogg With the legal cannabis industry generating $6.9 billion in sales in 2016, up 34% from 2015, it’s a no-brainer to say that much is at stake as the business inevitably grows. Much like the independent movie biz, the cannabis industry attracts investors looking for high-risk, high-reward investments, and as marijuana goes more mainstream, so does the funding mechanisms for the industry’s businesses.

Marijuana companies that are soaring in the stock market may tap bonds next

Medical marijuana companies will likely tap the Canadian bond market to fund growth as investors become more comfortable with the industry and the federal government gets set to legalize the drug by next year.

“There would be an appetite for more traditional debt arrangements and, given that leading cannabis companies have significant assets now, this may be one direction that we see the market go in the future,” said Cam Battley, executive vice president of Aurora Cannabis Inc., a licensed marijuana producer in Mountain View County, Alberta. “I suspect we’re headed in that direction right now.”

Washington Times Reports Bipartisan Bill would reclassify Marijuana as Schedule 3 Substance

Saturday, April 8, 2017

Bipartisan legislation proposed in the House on Thursday would make marijuana a Schedule 3 drug, removing cannabis from its current standing as a Schedule 1 substance alongside deadly contraband including ecstasy and heroin. 

By reclassifying weed in the same category as anabolic steroids, Congress would “make it easier for ill-patients and scientific and medical researchers to obtain marijuana,” the bill’s authors said in a statement Thursday.

10 Pot Products & THC Tech You Need to Know About

Cannabis legalization doesn’t only mean blazing great weed and banking big-time profits, it also brings astonishing advances in ancillary pot products and tech that seems to transcend itself each new year.